Rocket Pharmaceuticals Stock (NASDAQ: RCKT) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 793.64K |
Day Range | - - - |
52 Wk Range | 14.89 - 32.53 |
Market Cap | $2.07B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 55 |
Short Interest | 19.71% |
Days to Cover | 5.4 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Rocket Pharmaceuticals (NASDAQ:RCKT) through any online brokerage.
Other companies in Rocket Pharmaceuticals’s space includes: Syndax Pharmaceuticals (NASDAQ:SNDX), PTC Therapeutics (NASDAQ:PTCT), Protagonist Therapeutics (NASDAQ:PTGX), Agios Pharmaceuticals (NASDAQ:AGIO) and Novavax (NASDAQ:NVAX).
There is no analysis for Rocket Pharmaceuticals.
Rocket Pharmaceuticals has a consensus price target of $48.19.
The stock price for Rocket Pharmaceuticals (NASDAQ: RCKT) is $22.82 last updated July 19, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Rocket Pharmaceuticals.
Rocket Pharmaceuticals’s Q2 earnings are confirmed for Thursday, August 8, 2024.
There is no upcoming split for Rocket Pharmaceuticals.
Rocket Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.